![](/img/cover-not-exists.png)
P664 SB5 and reference adalimumab show cross-immunogenicity in patients with inflammatory bowel disease or rheumatoid arthritis
Gonçalves, J, Myung, G, Hong, E, Park, M, Jeong, D, Ghil, JVolume:
13
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.788
Date:
January, 2019
File:
PDF, 284 KB
english, 2019